Last updated: June 3, 2022
Sponsor: Segeberger Kliniken GmbH
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Coronary Artery Disease
Chest Pain
Vascular Diseases
Treatment
N/AClinical Study ID
NCT04014595
SK 110 -- 168/11
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Clinical inclusion criteria
- Age above 18 years and consentable
- Angiographically proven coronary artery disease
- Anginal symptoms and/or reproducible ischemia in the target area by ECG, functionalstress testing or fractional flow reserve
- Written informed consent Angiographic inclusion criteria
- De-novo lesion in a native coronary artery
- Target reference vessel diameter between 2.25 and 4.0 mm by visual estimation
- Luminal diameter reduction of 50-100% by visual estimation
- Severe calcification of the target lesion (for definition see appendix)
Exclusion
Exclusion Criteria: Clinical exclusion criteria
- Myocardial infarction (within 1 week)
- Decompensated heart failure
- Limited long term prognosis due to other conditions Angiographic exclusion criteria
- Target lesion is in a coronary artery bypass graft
- Target lesion is an in-stent restenosis
- Target vessel thrombus
Study Design
Total Participants: 100
Study Start date:
January 01, 2019
Estimated Completion Date:
July 31, 2025
Study Description
Connect with a study center
Herzzentrum Segeberger Kliniken GmbH
Bad Segeberg, 23795
GermanySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.